Digital Guide: An Overview of Next-Generation Sequencing
Dr. Valsamo Anagnastou, a thoracic oncologist and leader of the molecular tumor board at Johns Hopkins Kimmel Cancer Center, walks us through the intricacies of next-generation sequencing (NGS).
Next-generation sequencing (NGS), a type of molecular testing, can help you and your doctor decide on the best course of treatment in many kinds of cancer, especially in metastatic disease.
Here, Dr. Valsamo Anagnostou, a thoracic oncologist and leader of the Johns Hopkins Molecular Tumor Board, explains everything from the terminology your doctor might use, to how the testing is conducted, and its potential costs.
Your Digital Guide begins below: 5 Chapters / 5 Video Segments
Spencer Poiset
Liquid biopsy is a blood test that uses molecular profiling to identify a small amount of cancer cells or pieces of cancer cells circulating in your blood stream. It is a test often used when people have advanced or metastatic cancer to better personalize treatment and monitor response to ongoing therapies.